Viewing Study NCT01888302


Ignite Creation Date: 2025-12-25 @ 3:53 AM
Ignite Modification Date: 2026-02-25 @ 11:02 PM
Study NCT ID: NCT01888302
Status: COMPLETED
Last Update Posted: 2016-06-21
First Post: 2013-06-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Sirolimus, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients At High Risk for Cholangiocarcinoma Recurrence After Liver Transplant or Surgery
Sponsor: Mayo Clinic
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module